Blood Product Collection clinical trials

A Study of miRNA 371 in Patients With Germ Cell Tumors

This study looks at a special marker called miRNA 371 in blood tests for people with germ cell tumours. The aim is to see if this marker can help predict if the cancer might return, allowing doctors to better understand and manage the risk.